Johnna Perdrizet

613 total citations
50 papers, 411 citations indexed

About

Johnna Perdrizet is a scholar working on Epidemiology, General Health Professions and Gastroenterology. According to data from OpenAlex, Johnna Perdrizet has authored 50 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 9 papers in General Health Professions and 7 papers in Gastroenterology. Recurrent topics in Johnna Perdrizet's work include Pneumonia and Respiratory Infections (37 papers), Respiratory viral infections research (30 papers) and Child and Adolescent Health (9 papers). Johnna Perdrizet is often cited by papers focused on Pneumonia and Respiratory Infections (37 papers), Respiratory viral infections research (30 papers) and Child and Adolescent Health (9 papers). Johnna Perdrizet collaborates with scholars based in United States, Canada and United Kingdom. Johnna Perdrizet's co-authors include Matt Wasserman, Michele Wilson, Keith B.J. Franklin, Lindsay R. Grant, Raymond Farkouh, Liping Huang, Kyla Hayford, Cheryl McDade, Wanrudee Isaranuwatchai and Alejandro Cané and has published in prestigious journals such as Neurology, American Journal of Epidemiology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Johnna Perdrizet

44 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johnna Perdrizet United States 13 305 110 46 44 39 50 411
Katie Rose United Kingdom 7 160 0.5× 18 0.2× 31 0.7× 6 0.1× 9 0.2× 16 297
Lauren Allen United States 10 76 0.2× 46 0.4× 19 0.4× 4 0.1× 9 0.2× 27 252
Khaled Maman France 10 305 1.0× 51 0.5× 18 0.4× 17 0.4× 1 0.0× 14 633
Victoria Wilkins United States 9 42 0.1× 79 0.7× 125 2.7× 13 0.3× 43 1.1× 18 351
O. Marzouk United Kingdom 12 222 0.7× 193 1.8× 19 0.4× 53 1.4× 21 391
Deborah Lehman United States 11 149 0.5× 123 1.1× 18 0.4× 6 0.2× 30 503
Sharen Madden Canada 10 111 0.4× 52 0.5× 56 1.2× 28 0.7× 23 423
Mithilesh Dronavalli Australia 10 241 0.8× 8 0.1× 48 1.0× 20 0.5× 25 416
Matthew A. Crane United States 8 39 0.1× 24 0.2× 37 0.8× 7 0.2× 17 262
Bonnie J. Dattel United States 10 45 0.1× 23 0.2× 21 0.5× 26 0.7× 21 311

Countries citing papers authored by Johnna Perdrizet

Since Specialization
Citations

This map shows the geographic impact of Johnna Perdrizet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johnna Perdrizet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johnna Perdrizet more than expected).

Fields of papers citing papers by Johnna Perdrizet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johnna Perdrizet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johnna Perdrizet. The network helps show where Johnna Perdrizet may publish in the future.

Co-authorship network of co-authors of Johnna Perdrizet

This figure shows the co-authorship network connecting the top 25 collaborators of Johnna Perdrizet. A scholar is included among the top collaborators of Johnna Perdrizet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johnna Perdrizet. Johnna Perdrizet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peters, Marion G., et al.. (2025). Economic Evaluation of Transitioning to the 20-Valent Pneumococcal Conjugate Vaccine in the Dutch Paediatric National Immunisation Programme. Infectious Diseases and Therapy. 14(3). 527–547. 4 indexed citations
2.
Perdrizet, Johnna, et al.. (2025). Delayed Transition to 20-Valent Pneumococcal Conjugate Vaccine in Pediatric National Immunization Programs: Forgone Public Health and Economic Benefit. Infectious Diseases and Therapy. 14(3). 501–525. 2 indexed citations
3.
Rozenbaum, Mark H., Liping Huang, Johnna Perdrizet, et al.. (2024). Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants. Vaccine. 42(3). 573–582. 10 indexed citations
5.
Shinjoh, Masayoshi, et al.. (2024). Cost-effectiveness analysis of 20-valent pneumococcal conjugate vaccine for routine pediatric vaccination programs in Japan. Expert Review of Vaccines. 23(1). 485–497. 10 indexed citations
6.
Palmborg, Andreas, et al.. (2024). An economic evaluation of pneumococcal conjugate vaccines, PCV20 versus PCV15, for the prevention of pneumococcal disease in the Swedish pediatric population. Human Vaccines & Immunotherapeutics. 20(1). 2400751–2400751. 10 indexed citations
7.
Perdrizet, Johnna, et al.. (2024). Pediatric Pneumococcal Conjugate Vaccine and Dosing Schedule Perceptions Among Health Care Providers and Caregivers in Germany, France, Spain, and Greece. Infectious Diseases and Therapy. 13(9). 2017–2034. 2 indexed citations
9.
Perdrizet, Johnna, et al.. (2023). Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric population. Human Vaccines & Immunotherapeutics. 19(2). 2257426–2257426. 25 indexed citations
10.
Rozenbaum, Mark H., Liping Huang, Johnna Perdrizet, et al.. (2023). 1737. Cost-Effectiveness Analysis of Catch-Up Vaccination with the 20-Valent Pneumococcal Conjugate Vaccine. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations
12.
Le, Lan, et al.. (2022). Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies. Value in Health. 26(4). 598–611. 17 indexed citations
14.
Huang, Liping, et al.. (2022). PCV13 Pediatric Routine Schedule Completion and Adherence Before and During the COVID-19 Pandemic in the United States. Infectious Diseases and Therapy. 11(6). 2141–2158. 3 indexed citations
16.
Perdrizet, Johnna, et al.. (2021). Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants. Infectious Diseases and Therapy. 10(4). 2625–2642. 8 indexed citations
17.
Wilson, Michele, Cheryl McDade, Johnna Perdrizet, et al.. (2021). Validation of a Novel Forecasting Method for Estimating the Impact of Switching Pneumococcal Conjugate Programs: Evidence from Belgium. Infectious Diseases and Therapy. 10(3). 1765–1778. 6 indexed citations
18.
Perdrizet, Johnna, et al.. (2020). Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants. Human Vaccines & Immunotherapeutics. 17(4). 1162–1172. 9 indexed citations
19.
Perdrizet, Johnna, David D’Souza, Julia Skliarenko, et al.. (2020). A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy Versus Two-Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer. International Journal of Radiation Oncology*Biology*Physics. 107(3). 512–521. 11 indexed citations
20.
Perdrizet, Johnna, et al.. (2012). The effect of morphine dependence on impulsive choice in rats. Psychopharmacology. 223(4). 477–487. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026